Ofatumumab treatment of fludarabine and alemtuzumab refractory patients

Abstract

Review article summarizes current usage of ofatumumab , a fully human monoclonal anti-CD20 antibody, in treatment of chronic lymphocytic leukemia.

Keywords

• CLL, ofatumumab
• fluradarabine refractory
• chronic lymphocytic leukemia